Inter- And intrareader agreement for categorization of background parenchymal enhancement at baseline and after training

American Journal of Roentgenology

Volumn 203, Issue 1, 2014, Pages 209-215

  Melsaether, Amy ^a   McDermott, Meredith ^a   Gupta, Dipti ^a,b   Pysarenko, Kristine ^a   Shaylor, Sara D ^a   Moy, Linda ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

Background parenchymal enhancement; Breast MRI; Interreader agreement; Intrareader agreement; Training

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; BACKGROUND PARENCHYMAL ENHANCEMENT; BREAST MRI; BREAST TUMOR; FEMALE; HUMAN; IMAGE ENHANCEMENT; INTERREADER AGREEMENT; INTRAREADER AGREEMENT; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REPRODUCIBILITY; RETROSPECTIVE STUDY; TRAINING;

BACKGROUND PARENCHYMAL ENHANCEMENT; BREAST MRI; INTERREADER AGREEMENT; INTRAREADER AGREEMENT; TRAINING;

ADULT; AGED; BREAST NEOPLASMS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 84906080848     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.13.10952     Document Type: Article

References (45)

1. Kuhl C, Weigel S, Schrading S, et al. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA Trial. J Clin Oncol 2010; 28:1450-1457
2. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004; 292:1317-1325 (Pubitemid 39223222)
3. Trecate G, Vergnaghi D, Manoukian S, et al. MRI in the early detection of breast cancer in women with high genetic risk. Tumori 2006; 92:517-523 (Pubitemid 46166305)
4. Warner E, Plewes DB, Shumak RS, et al. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 2001; 19:3524-3531 (Pubitemid 32730090)
5. Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005; 23:8469-8476
6. Berg WA, Zhang Z, Lehrer D, et al.; ACRIN 6666 Investigators. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA 2012; 307:1394-1404
7. King V, Brooks JD, Bernstein JL, Reiner AS, Pike MC, Morris EA. Background parenchymal enhancement at breast MR imaging and breast cancer risk. Radiology 2011; 260:50-60
8. Kuhl CK, Bieling HB, Gieseke J, et al. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclicalphase dependency. Radiology 1997; 203:137-144 (Pubitemid 27142721)
9. Hussain Z, Roberts N, Whitehouse GH, García-Fiñana M, Percy D. Estimation of breast volume and its variation during the menstrual cycle using MRI and stereology. Br J Radiol 1999; 72:236-245 (Pubitemid 29154669)
10. Graham SJ, Stanchev PL, Lloyd-Smith JO, Bronskill MJ, Plewes DB. Changes in fibroglandular volume and water content of breast tissue during the menstrual cycle observed by MR imaging at 1.5 T. J Magn Reson Imaging 1995; 5:695-701
11. Delille J-P, Slanetz PJ, Yeh ED, Kopans DB, Halpern EF, Garrido L. Hormone replacement therapy in postmenopausal women: breast tissue perfusion determined with MR imaging-initial observations. Radiology 2005; 235:36-41 (Pubitemid 40432232)
12. Harvey JA, Santen RJ, Petroni GR, et al. Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices. Menopause 2008; 15:67-73
13. Pfleiderer SO, Sachse S, Sauner D, et al. Changes in magnetic resonance mammography due to hormone replacement therapy. Breast Cancer Res 2004; 6:R232-R238
14. King V, Kaplan JB, Pike MC, et al. Impact of tamoxifen on fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging. Breast J 2012; 18:527-534
15. Eng-Wong J, Orzano-Birgani J, Chow CK, et al. Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer. Cancer Epidemiol Biomarkers Prev 2008; 17:1696-1701
16. Oksa S, Parkkola R, Luukkaala T, Mäenpää J. Breast magnetic resonance imaging findings in women treated with toremifene for premenstrual mastalgia. Acta Radiol 2009; 50:984-989
17. Mousa NA, Eiada R, Crystal P, Nayot D, Casper RF. The effect of acute aromatase inhibition on breast parenchymal enhancement in magnetic resonance imaging: a prospective pilot clinical trial. Menopause 2012; 19:420-425
18. King V, Goldfarb SB, Brooks JD, et al. Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging. Radiology 2012; 264:670-678
19. Cubuk R, Tasali N, Narin B, Keskiner F, Celik L, Guney S. Correlation between breast density in mammography and background enhancement in MR mammography. Radiol Med (Torino) 2010; 115:434-441
20. Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003; 138:168-175 (Pubitemid 36231622)
21. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 1996; 276:33-38 (Pubitemid 26231053)
22. Wolfe JN. Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer 1976; 37:2486-2492
23. Wolfe JN. Breast patterns as an index of risk for developing breast cancer. AJR 1976; 126:1130-1137
24. Byrne C, Schairer C, Wolfe JN, et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 1995; 87:1622-1629
25. Boyd NF, Dite GS, Stone J, et al. Heritability of mammographic density, as risk for breast cancer. N Engl J Med 2002; 347:886-894
26. DeMartini WB, Liu F, Peacock S, et al. Background parenchymal enhancement on breast MRI: impact on diagnostic performance. AJR 2012; 198:[web]W373-W380
27. Hambly NM, Liberman L, Dershaw DD, Brennan S, Morris EA. Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval followup. AJR 2011; 196:218-224
28. Ciatto S, Houssami N, Apruzzese A, et al. Categorizing breast mammographic density: intra- and interobserver reproducibility of BI-RADS density categories. Breast 2005; 14:269-275 (Pubitemid 41110187)
29. Bernardi D, Pellegrini M, Di Michele S, et al. Interobserver agreement in breast radiological density attribution according to BI-RADS quantitative classification. Radiol Med (Torino) 2012; 117:519-528
30. Berg WA, Campassi C, Langenberg P, Sexton MJ. Breast Imaging Reporting and Data System: inter- and intraobserver variability in feature analysis and final assessment. AJR 2000; 174:1769-1777 (Pubitemid 30346755)
31. Redondo A, Comas M, Macià F, et al. Inter- and intraradiologist variability in the BI-RADS assessment and breast density categories for screening mammograms. Br J Radiol 2012; 85:1465-1470
32. Lazarus E, Mainiero MB, Schepps B, Koelliker SL, Livingston LS. BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value. Radiology 2006; 239:385-391
33. Park CS, Lee JH, Yim HW, et al. Observer agreement using the ACR Breast Imaging Reporting and Data System (BI-RADS)-Ultrasound, First Edition (2003). Korean J Radiol 2007; 8:397-402
34. Shin HJ, Kim HH, Cha JH, et al. Automated ultrasound of the breast for diagnosis: interobserver agreement on lesion detection and characterization. AJR 2011; 197:747-754
35. Morris EA. Diagnostic breast MR imaging: current status and future directions. Radiol Clin North Am 2007; 45:863-880 (Pubitemid 47410063)
36. Molleran V, Mahoney MC. The BI-RADS breast magnetic resonance imaging lexicon. Magn Reson Imaging Clin N Am 2010; 18:171-185
37. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33:159-174 (Pubitemid 8054849)
38. American College of Radiology. Breast Imaging Reporting and Data System (BI- RADS). Reston, VA: American College of Radiology, 1992
39. D'Orsi CJ, Mendelson, EB, Ikeda DM, et al. Breast Imaging Reporting and Data System: ACR BI-RADS-breast imaging atlas. Reston, VA: American College of Radiology, 2003
40. Morris EA, Comstock CE, Lee CH, et al. BIRADS: magnetic resonance imaging, 2nd ed. In: D'Orsi CJ, Sickles EA, Mendelson EB, et al. Breast Imaging Reporting and Data System: ACR BI-RADS-breast imaging atlas. Reston, VA, American College of Radiology, 2013
41. Timmers JMH, van Doorne-Nagtegaal HJ, Verbeek ALM, et al. A dedicated BI-RADS training programme: effect on the inter-observer variation among screening radiologists. Eur J Radiol 2012; 81:2184-2188
42. Berg WA, Blume JD, Cormack JB, et al. Training the ACRIN 6666 investigators and effects of feedback on breast ultrasound interpretive performance and agreement in BI-RADS ultrasound feature analysis. AJR 2012; 199:224-235
43. Berg WA, D'Orsi CJ, Jackson VP, et al. Does training in the Breast Imaging Reporting and Data System (BI-RADS) improve biopsy recommendations or feature analysis agreement with experienced breast imagers at mammography? Radiology 2002; 224:871-880 (Pubitemid 34919826)
44. King V, Gu Y, Kaplan JB, Brooks JD, Pike MC, Morris EA. Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI. Eur Radiol 2012; 22:2641-2647
45. Checka CM, Chun JE, Schnabel FR, Lee J, Toth H. The relationship of mammographic density and age: implications for breast cancer screening. AJR 2012; 198:[web]W292-W295